CERo Therapeutics
CERO
CERO was delisted on the 30th of October, 2025.
9 hedge funds and large institutions have $7.49M invested in CERo Therapeutics in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
2% more capital invested
Capital invested by funds: $7.33M → $7.49M (+$157K)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
10% less funds holding
Funds holding: 10 → 9 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$785K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$543K |
| 2 |
CS
Clear Street
New York
|
-$218K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MC
1
Meteora Capital
Boca Raton,
Florida
| $2.68M | +$785K | +36 | +42% |
|
|
MTCM
2
Mint Tower Capital Management
Amsterdam,
Netherlands
| $1.55M | – | – | – |
|
|
YCM
3
Yakira Capital Management
Westport,
Connecticut
| $1.2M | – | – | – |
|
|
CS
4
Clear Street
New York
| $601K | -$218K | -10 | -27% |
|
5
Walleye Capital
New York
| $527K | – | – | – |
|
|
WRBC
6
W.R. Berkley Corp
Greenwich,
Connecticut
| $519K | – | – | – |
|
7
Walleye Trading
New York
| $297K | – | – | – |
|
8
Geode Capital Management
Boston,
Massachusetts
| $117K | – | – | – |
|
|
PCM
9
PenderFund Capital Management
Vancouver,
British Columbia, Canada
| $1.48K | – | – | – |
|
|
CF
10
Cantor Fitzgerald
New York
| $2 | – | – | – |
|
|
SCM
11
Shaolin Capital Management
Miami,
Florida
| – | -$543K | -25 | Closed |
|
CERO Hedge Fund Activity: Q4 2023 in Review
9 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics (CERO) for Q4 2023, worth a combined $7.49M — up 2.1% from $7.33M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CERO and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Meteora Capital, adding an estimated $785K. The largest seller was Shaolin Capital Management, exiting entirely with an estimated $543K sold.
- 9 institutional investors held CERo Therapeutics (CERO) as of Q4 2023, down from 10 in Q3 2023.
- Funds reported $7.49M of CERo Therapeutics stock for Q4 2023, up 2.1% quarter-over-quarter.
- 0 funds opened new CERo Therapeutics positions in Q4 2023 and 1 closed out, a net change of -1 holder.
- The largest CERo Therapeutics buyer in Q4 2023 was Meteora Capital, an estimated $785K added.
- The largest CERo Therapeutics seller in Q4 2023 was Shaolin Capital Management, an estimated $543K sold.
Based on aggregated 13F filings for Q4 2023.